Account-creators
1,040
edits
Jensflorian (talk | contribs) (Category update) |
Jensflorian (talk | contribs) (→Uncommon Astrocytomas: link) |
||
(7 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
An '''astrocytoma''' is a neoplasm derived from an [[neurohistology|astrocyte]]. | An '''astrocytoma''' is a neoplasm thought to be derived from an [[neurohistology|astrocyte]]. Astrocytomas/Glioblastomas are most common type of glial tumours and grouped together with [[Oligodendroglioma]] and glioneuronal tumours in the current WHO brain tumor classficiation. Some (often circumscribed) astrocytic tumors and pediatric tumours are biologically different from adult-onset diffuse astrocytomas. An overview of other CNS tumours is found in the ''[[CNS tumours]]'' article. | ||
=Categorization= | |||
Astrocytomas can be categorized in serveral ways. | |||
* Common vs. uncommon tumours. | |||
* Adult vs. pediatric tumours. | |||
* Circumscribed vs. diffusely growing astrocytomas. | |||
Until 2016 WHO classification, roman numerals I-IV were used for grading. The current 2021 WHO classification uses arabic numbering 1-4 for CNS WHO grading instead. | |||
=Overview= | =Overview= | ||
These astrocytic tumors are frequently diagnosed in neuropathology practice: | |||
{| class="wikitable sortable" | {| class="wikitable sortable" | ||
! Name | ! Name | ||
Line 66: | Line 74: | ||
|} | |} | ||
=Common= | =Adult-type astrocytomas= | ||
*[[Astrocytoma, IDH-mutant]]. | |||
*[[Glioblastoma]], IDH wildtype. | |||
*[[High-grade astrocytoma with piloid features]]. | |||
*[[Pleomorphic xanthroastrocytoma]]. | |||
*[[Subependymal giant cell astrocytoma]]. | |||
*Chordoid glioma. | |||
=Pediatric-type astrocytomas= | |||
*[[Pilocytic astrocytoma]]. | |||
*[[Pediatric-type diffuse high-grade glioma]]. | |||
*[[Pediatric-type diffuse low-grade glioma]]. | |||
*[[Astroblastoma]], MN1-altered. | |||
=Diffuse growing astrocytomas= | |||
*[[Astrocytoma, IDH-mutant]]. | |||
*[[Glioblastoma]], IDH wildtype. | |||
*[[Diffuse midline glioma, H3 K27-altered]]. | |||
*[[Diffuse hemispheric glioma, H3 G34-mutant]]. | |||
*[[Diffuse astrocytoma, MYB- or MYBL-altered]]. | |||
*Diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype. | |||
*Angiocentric glioma. | |||
*Diffuse low-grade glioma, MAPK pathway-altered. | |||
=Circumscribed astrocytomas= | |||
*[[Pilocytic astrocytoma]]. | |||
*[[High-grade astrocytoma with piloid features]]. | |||
*[[Pleomorphic xanthroastrocytoma]]. | |||
*[[Subependymal giant cell astrocytoma]]. | |||
*[[Chordoid glioma]]. | |||
*[[Astroblastoma]], MN1-altered. | |||
=Common Astrocytomas= | |||
==Pilocytic astrocytoma== | ==Pilocytic astrocytoma== | ||
* Benign, cystic, infratentorial. | * Benign, cystic, infratentorial. | ||
Line 77: | Line 117: | ||
* Astrocytoma, IDH mutant are less common than glioblastoma. | * Astrocytoma, IDH mutant are less common than glioblastoma. | ||
* Grade 2-4 depends on histological and molecular criteria: | * Grade 2-4 depends on histological and molecular criteria: | ||
{{Main|Astrocytoma, IDH-mutant}} | |||
=== Astrocytoma, IDH mutant grade 2=== | === Astrocytoma, IDH mutant grade 2=== | ||
Line 82: | Line 123: | ||
* Typically seen in adults. | * Typically seen in adults. | ||
* Usually shows progression to astrocytoma IDH mutant, grade 4. | * Usually shows progression to astrocytoma IDH mutant, grade 4. | ||
===Astrocytoma, IDH mutant grade 3=== | ===Astrocytoma, IDH mutant grade 3=== | ||
Line 89: | Line 129: | ||
* Increased cellularity, cell atypia and mitotic activity. | * Increased cellularity, cell atypia and mitotic activity. | ||
* Lacks endothelial proliferations and necrosis of glioblastoma. | * Lacks endothelial proliferations and necrosis of glioblastoma. | ||
===Astrocytoma, IDH mutant grade 4=== | ===Astrocytoma, IDH mutant grade 4=== | ||
Line 103: | Line 142: | ||
{{Main|Glioblastoma}} | {{Main|Glioblastoma}} | ||
=Uncommon= | =Uncommon Astrocytomas= | ||
==Diffuse astrocytoma, MYB- or MYBL-altered== | ==Diffuse astrocytoma, MYB- or MYBL-altered== | ||
* Pediatric-type diffuse low-grade glioma. | * Pediatric-type diffuse low-grade glioma. | ||
Line 119: | Line 158: | ||
* Large lipidized cells mimicking a malignant tumor | * Large lipidized cells mimicking a malignant tumor | ||
{{Main|Pleomorphic xanthoastrocytoma}} | {{Main|Pleomorphic xanthoastrocytoma}} | ||
==Diffuse midline glioma, H3 K27-altered== | ==Diffuse midline glioma, H3 K27-altered== | ||
Line 136: | Line 163: | ||
* Mostly in children and adolescents. | * Mostly in children and adolescents. | ||
* Includes diffuse intrinsic pontine gliomas (DPIG). | * Includes diffuse intrinsic pontine gliomas (DPIG). | ||
{{Main|Diffuse midline glioma, H3 K27-altered}} | |||
==Diffuse hemispheric glioma, H3 G34-mutant== | ==Diffuse hemispheric glioma, H3 G34-mutant== | ||
Line 155: | Line 172: | ||
* H3F3A missense mutation G34R or G34V. | * H3F3A missense mutation G34R or G34V. | ||
{{Main|Diffuse hemispheric glioma, H3 G34-mutant}} | {{Main|Diffuse hemispheric glioma, H3 G34-mutant}} | ||
==High-grade astrocytoma with piloid features== | |||
* Frequent in posterior fossa (75%). | |||
* 1-3% of all brain tumors. | |||
* Histology may resemble Glionblastoma or Pleomorphic xanthoastrocytoma. | |||
* Tumor is enriched for piloid cell processes. | |||
* ATRX nuclear loss is frequent. | |||
* Usu. MAPK-pathway alterations + CDKN2A homozygous deletion. | |||
* Distinct methylation profile. | |||
{{Main|High-grade astrocytoma with piloid features}} | |||
==Gliomatosis cerebri== | |||
* Depreceated entity. | |||
* Was used for extensively diffusely growing astrocytic neoplasms. | |||
**Introduced in 1938 as a post-mortem diagnosis.<ref>SAMUEL NEVIN - GLIOMATOSIS CEREBRI, DOI: http://dx.doi.org/10.1093/brain/61.2.170 170-191 First published online: 1 June 1938</ref> | |||
**Since 2016 it is no longer considered a distinct entity.<ref>{{Cite journal | last1 = Johnson | first1 = DR. | last2 = Guerin | first2 = JB. | last3 = Giannini | first3 = C. | last4 = Morris | first4 = JM. | last5 = Eckel | first5 = LJ. | last6 = Kaufmann | first6 = TJ. | title = 2016 Updates to the WHO Brain Tumor Classification System: What the Radiologist Needs to Know. | journal = Radiographics | volume = 37 | issue = 7 | pages = 2164-2180 | month = | year = | doi = 10.1148/rg.2017170037 | PMID = 29028423 }}</ref><ref>{{Cite journal | last1 = Herrlinger | first1 = U. | last2 = Jones | first2 = DT. | last3 = Glas | first3 = M. | last4 = Hattingen | first4 = E. | last5 = Gramatzki | first5 = D. | last6 = Stuplich | first6 = M. | last7 = Felsberg | first7 = J. | last8 = Bähr | first8 = O. | last9 = Gielen | first9 = GH. | title = Gliomatosis cerebri: no evidence for a separate brain tumor entity. | journal = Acta Neuropathol | volume = | issue = | pages = | month = Oct | year = 2015 | doi = 10.1007/s00401-015-1495-z | PMID = 26493382 }}</ref> | |||
* More than 3 lobes have to be involved, us. bilateral (radiology required). | |||
* biologic behaviour corresponds to WHO III (ICD-O: 9381/3) | |||
* Based on presence / absence of a solid component authors propose two types:<ref>{{Cite journal | last1 = Seiz | first1 = M. | last2 = Tuettenberg | first2 = J. | last3 = Meyer | first3 = J. | last4 = Essig | first4 = M. | last5 = Schmieder | first5 = K. | last6 = Mawrin | first6 = C. | last7 = von Deimling | first7 = A. | last8 = Hartmann | first8 = C. | title = Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence for molecular subtypes. | journal = Acta Neuropathol | volume = 120 | issue = 2 | pages = 261-7 | month = Aug | year = 2010 | doi = 10.1007/s00401-010-0701-2 | PMID = 20514489 }}</ref> | |||
** GC type 1: classic diffuse growth, without IDH1/2 mutation. | |||
** GC type 2: with a solid portion, mostly IDH1 mutant. | |||
* Genetic studies indicate strong overlap with diffuse astrocytic gliomas, oligodendrogliomas and glioblastoma. | |||
==Gliosarcoma== | ==Gliosarcoma== |